These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
343 related items for PubMed ID: 32580789
1. A multi-biomarker disease activity score can predict sustained remission in rheumatoid arthritis. Ma MHY, Defranoux N, Li W, Sasso EH, Ibrahim F, Scott DL, Cope AP. Arthritis Res Ther; 2020 Jun 24; 22(1):158. PubMed ID: 32580789 [Abstract] [Full Text] [Related]
2. Predictive value of a multi-biomarker disease activity score for clinical remission and radiographic progression in patients with early rheumatoid arthritis: a post-hoc study of the OPERA trial. Brahe CH, Østergaard M, Johansen JS, Defranoux N, Wang X, Bolce R, Sasso EH, Ørnbjerg LM, Hørslev-Petersen K, Stengaard-Pedersen K, Junker P, Ellingsen T, Ahlquist P, Lindegaard H, Linauskas A, Schlemmer A, Dam MY, Hansen I, Lottenburger T, Ammitzbøll C, Jørgensen A, Krintel SB, Raun J, Hetland ML. Scand J Rheumatol; 2019 Jan 24; 48(1):9-16. PubMed ID: 29985080 [Abstract] [Full Text] [Related]
3. An evaluation of molecular and clinical remission in rheumatoid arthritis by assessing radiographic progression. van der Helm-van Mil AH, Knevel R, Cavet G, Huizinga TW, Haney DJ. Rheumatology (Oxford); 2013 May 24; 52(5):839-46. PubMed ID: 23287359 [Abstract] [Full Text] [Related]
4. A multi-biomarker disease activity score tracks clinical response consistently in patients with rheumatoid arthritis treated with different anti-tumor necrosis factor therapies: A retrospective observational study. Hirata S, Li W, Defranoux N, Cavet G, Bolce R, Yamaoka K, Saito K, Tanaka Y. Mod Rheumatol; 2015 May 24; 25(3):344-9. PubMed ID: 25295918 [Abstract] [Full Text] [Related]
5. Differences in disease activity measures in patients with rheumatoid arthritis who achieved DAS, SDAI, or CDAI remission but not Boolean remission. Aletaha D, Wang X, Zhong S, Florentinus S, Monastiriakos K, Smolen JS. Semin Arthritis Rheum; 2020 Apr 24; 50(2):276-284. PubMed ID: 31590930 [Abstract] [Full Text] [Related]
6. A multi-biomarker score measures rheumatoid arthritis disease activity in the BeSt study. Hirata S, Dirven L, Shen Y, Centola M, Cavet G, Lems WF, Tanaka Y, Huizinga TW, Allaart CF. Rheumatology (Oxford); 2013 Jul 24; 52(7):1202-7. PubMed ID: 23392591 [Abstract] [Full Text] [Related]
7. The multi-biomarker disease activity score tracks response to rituximab treatment in rheumatoid arthritis patients: a post hoc analysis of three cohort studies. Roodenrijs NMT, de Hair MJH, Wheater G, Elshahaly M, Tekstra J, Teng YKO, Lafeber FPJG, Hwang CC, Liu X, Sasso EH, van Laar JM. Arthritis Res Ther; 2018 Nov 20; 20(1):256. PubMed ID: 30458871 [Abstract] [Full Text] [Related]
9. Active foot synovitis in patients with rheumatoid arthritis: applying clinical criteria for disease activity and remission may result in underestimation of foot joint involvement. Wechalekar MD, Lester S, Proudman SM, Cleland LG, Whittle SL, Rischmueller M, Hill CL. Arthritis Rheum; 2012 May 20; 64(5):1316-22. PubMed ID: 22135142 [Abstract] [Full Text] [Related]
10. Comparable long-term outcomes between DAS28-ESR remission criteria and ACR/EULAR definitions in patients with established rheumatoid arthritis. Ramírez J, Inciarte-Mundo J, Cuervo A, Celis R, Ruiz-Esquide V, Castellanos-Moreira R, Ponce A, Gómez-Puerta JA, Sanmartí R, Cañete JD. Clin Rheumatol; 2021 Jul 20; 40(7):2665-2672. PubMed ID: 33506371 [Abstract] [Full Text] [Related]
11. Predictive ability, validity, and responsiveness of the multi-biomarker disease activity score in patients with rheumatoid arthritis initiating methotrexate. Luedders BA, Johnson TM, Sayles H, Thiele GM, Mikuls TR, O'Dell JR, England BR. Semin Arthritis Rheum; 2020 Oct 20; 50(5):1058-1063. PubMed ID: 32911284 [Abstract] [Full Text] [Related]
15. How much does Disease Activity Score in 28 joints ESR and CRP calculations underestimate disease activity compared with the Simplified Disease Activity Index? Fleischmann R, van der Heijde D, Koenig AS, Pedersen R, Szumski A, Marshall L, Bananis E. Ann Rheum Dis; 2015 Jun 20; 74(6):1132-7. PubMed ID: 25143522 [Abstract] [Full Text] [Related]
16. Validation of the adjusted multi-biomarker disease activity score as a prognostic test for radiographic progression in rheumatoid arthritis: a combined analysis of multiple studies. Curtis JR, Weinblatt ME, Shadick NA, Brahe CH, Østergaard M, Hetland ML, Saevarsdottir S, Horton M, Mabey B, Flake DD, Ben-Shachar R, Sasso EH, Huizinga TW. Arthritis Res Ther; 2021 Jan 04; 23(1):1. PubMed ID: 33397438 [Abstract] [Full Text] [Related]
17. The effect of deep or sustained remission on maintenance of remission after dose reduction or withdrawal of etanercept in patients with rheumatoid arthritis. Tanaka Y, Smolen JS, Jones H, Szumski A, Marshall L, Emery P. Arthritis Res Ther; 2019 Jul 05; 21(1):164. PubMed ID: 31277720 [Abstract] [Full Text] [Related]
18. Remission and radiographic outcome in rheumatoid arthritis: application of the 2011 ACR/EULAR remission criteria in an observational cohort. Lillegraven S, Prince FH, Shadick NA, Bykerk VP, Lu B, Frits ML, Iannaccone CK, Kvien TK, Haavardsholm EA, Weinblatt ME, Solomon DH. Ann Rheum Dis; 2012 May 05; 71(5):681-6. PubMed ID: 21994234 [Abstract] [Full Text] [Related]
19. Predictors and the optimal duration of sustained remission in rheumatoid arthritis. Yilmaz-Oner S, Gazel U, Can M, Atagunduz P, Direskeneli H, Inanc N. Clin Rheumatol; 2019 Nov 05; 38(11):3033-3039. PubMed ID: 31270696 [Abstract] [Full Text] [Related]
20. Continual Maintenance of Remission Defined by the ACR/EULAR Criteria in Daily Practice Leads to Better Functional Outcomes in Patients with Rheumatoid Arthritis. Shidara K, Nakajima A, Inoue E, Hoshi D, Sugimoto N, Seto Y, Tanaka E, Momohara S, Taniguchi A, Yamanaka H. J Rheumatol; 2017 Feb 05; 44(2):147-153. PubMed ID: 27909083 [Abstract] [Full Text] [Related] Page: [Next] [New Search]